Adbiotech to issue ₩1.0bn convertible bonds due Nov 20, 2029
Adbiotech filed on Oct 30, 2026 to issue ₩1.0bn of convertible bonds with a 6.0% coupon, maturing Nov 20, 2029. The conversion price is ₩1,000, which would issue 1,000,000 shares, equal to 3.1% of total shares. The refixing floor price is ₩700.
Key facts
| Face amount | ₩1.0bn |
|---|---|
| Conversion price | ₩1,000 |
| Shares issuable on conversion | 1,000,000 shares |
| % of total shares | 3.1% |
| Maturity date | Nov 20, 2029 |
| Coupon rate | 6.0% |
| Refixing floor price | ₩700 |
Comparison
| Amount as % of FY2025 revenue (calculated) | 7.8% |
|---|---|
| Revenue 2025 | ₩12.9bn |
| Revenue 2024 | ₩11.1bn |
| Revenue 2023 | ₩10.5bn |
Context
In the 12 months before this filing, the company issued ₩10.3bn of CB/BW/EB across 1 issue, with 10,386,505 potential new shares, equal to 87.5% of shares. Including this filing, potential new shares are 96.0% of shares, by our calculation. The filing amounts to 7.8% of FY2025 revenue, by our calculation.
Key metrics
Potential dilution
| CB/BW/EB issued, last 12 months | ₩12.3bn |
|---|---|
| Rights offering new shares, last 12 months | 0 shares |
| Potential new shares, last 12 months | 12,386,505 shares |
| Potential new shares, % of shares | 104.4% |
| Conversion price adjustments, last 12 months | 1 |
Source: DART (Financial Supervisory Service) · Original filing on DART ↗